R&D Pipeline
LysiThru™ Proven Technology is a proprietary discovery platform developed by Lysigen which allows for the high-throughput identification and engineering of Gram-positive and Gram-negative lysins with commercial potential. This platform has already been successful producing several lead lysins against difficult-to-target organisms (currently in pre-clinical development). Relying on LysiThru™, Lysigen has started to develop lysin leads against a number of ESKAPE pathogens, including MDR Gram-negative pathogens.

本站使用百度智能门户搭建 管理登录